Post job

Corbus Pharmaceuticals overview

Industry
Biotechnology
Revenue
Headquarters
Employees
76
Founded in
Website
Organization type
Public
Social media
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of endocannabinoid system-targeting synthetic drug candidates. The Company's lead product candidate, lenabasum, is a novel, synthetic, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Corbus is also developing a pipeline of drug candidates from more than 600 novel compounds targeting the endocannabinoid system. The pipeline includes CRB-4001, a 2nd generation, peripherally-restricted, selective cannabinoid receptor type 1 (CB1) inverse agonist. Potential indications for CRB-4001 include NASH, among others. Corbus plans to start a Phase 1 study of CRB-4001 in 2019, intended to be followed by a National Institutes of Health (NIH)-funded proof-of-concept Phase 2 study.
Corbus Pharmaceuticals is a small health care company based in Massachusetts with only 76 employees and an annual revenue of $881,705.

Corbus Pharmaceuticals's mission statement

To leveraging our expertise in immunology to fulfill our purpose of developing innovative new medicines that improve the lives of people living with inflammatory, fibrotic, and metabolic diseases, and cancer.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Corbus Pharmaceuticals employee reviews

Be the first to review!

Do you work at Corbus Pharmaceuticals?

Help job seekers learn about working at Corbus Pharmaceuticals

Job openings at Corbus Pharmaceuticals
7 positions

On this page

Be the first to review Corbus Pharmaceuticals

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Corbus Pharmaceuticals?

The team at Corbus Pharmaceuticals

  • The founders of Corbus Pharmaceuticals are Yuval Cohen, Sean F. Moran Cpa, Bruce Montgomery, Jonathan Mow and Mark Tepper.
  • The key people at Corbus Pharmaceuticals are Yuval Cohen, Sean F. Moran Cpa and Bruce Montgomery.
Key people
Yuval Cohen
Sean F. Moran Cpa
Bruce Montgomery
Jonathan Mow
Mark Tepper

Corbus Pharmaceuticals rankings

Corbus Pharmaceuticals is ranked #4 on the Best Health Care companies to work for in Norwood, MA list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Corbus Pharmaceuticals salaries

Average Corbus Pharmaceuticals salary
$45,440
yearly
$21.85 hourly
Updated March 14, 2024

Rate Corbus Pharmaceuticals' promotion and raise policies.

Zippia waving zebra

Do you work at Corbus Pharmaceuticals?

Does Corbus Pharmaceuticals actively promote diversity and inclusion?

Corbus Pharmaceuticals financial performance

6.8
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Corbus Pharmaceuticals currently has 881.7K in revenue. Corbus Pharmaceuticals's most recent quarter produced 97.3k (q3'2021).

Corbus Pharmaceuticals annual revenue

$36M
$29M
$22M
$14M
$7M
$0
2016
2017
2018
2019
2020
2021

Are you an executive, HR leader, or brand manager at Corbus Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Corbus Pharmaceuticals FAQs

Search for jobs

Zippia gives an in-depth look into the details of Corbus Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Corbus Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Corbus Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Corbus Pharmaceuticals. The data presented on this page does not represent the view of Corbus Pharmaceuticals and its employees or that of Zippia.

Corbus Pharmaceuticals may also be known as or be related to CORBUS PHARMACEUTICALS HOLDINGS INC., Corbus Pharmaceuticals, Corbus Pharmaceuticals Holdings Inc, Corbus Pharmaceuticals Holdings, Inc. and Corbus Pharmaceuticals, Inc.